Despite huge advances in screening, detection and care, it is estimated that half of us will experience cancer in our lifetime. Cancer vaccines are an exciting new approach to the treatment of cancer, and a number of products are entering clinical trials across the globe.

In this seminar, two experts will talk about their research into the use of mRNA vaccines in cancer treatment and answer your questions:

Professor Robin Shattock is Head of Mucosal Infection and Immunity in the Department of Infectious Disease at Imperial College London. Professor Shattock will talk about the basic biology of mRNA vaccines and their potential use in cancer.

Dr David Pinato is Clinician Scientist in the Department of Surgery and Cancer at Imperial College London and a Consultant Oncologist at Imperial College Healthcare NHS Trust. Dr Pinato will talk about his research programme including early trials of mRNA cancer immunotherapies.